EGRX EAGLE PHARMACEUTICALS IN: institutional ownership and insider trading
2 funds reported holding $11.6K of EAGLE PHARMACEUTICALS IN in their latest 13F filings; in Q2 2026 funds net bought $0, with 0 new positions and 0 funds selling out.
Largest institutional holders of EGRX
- Stanley-Laman Group, Ltd. — $11.4K
- Archer Investment Corp — $235